Alan Go to Anti-Arrhythmia Agents
This is a "connection" page, showing publications Alan Go has written about Anti-Arrhythmia Agents.
Connection Strength
1.488
-
Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications. Am J Cardiol. 2020 02 15; 125(4):553-561.
Score: 0.653
-
Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):49-58.
Score: 0.462
-
Association of Rate-Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation. J Am Heart Assoc. 2025 Jun 17; 14(12):e038511.
Score: 0.240
-
Pharmacotherapy in Medicare beneficiaries with atrial fibrillation. Heart Rhythm. 2012 Sep; 9(9):1403-8.
Score: 0.097
-
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 11; 104(22):1850-1858.
Score: 0.037